Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/2010
04/01/2010US20100080830 Systemic delivery of antiviral agents
04/01/2010US20100080824 A formulation comprising a cell culture extract of an isolated virus is identified to be morphologically and phylogenetically similar to the known member of coronaviruses; kits comprising containers containing the formulation used in medical diagnosis, as vaccines and antibodies
04/01/2010US20100080818 Expression and Characterization of HIV-1 Envelope Protein Associated with Broadly Cross Reactive Neutralizing Antibody Response
04/01/2010US20100080813 Neutralizing anti-influenza a virus antibodies and uses thereof
04/01/2010US20100080807 Methods and Compositions for Treating Viral Hemorrhagic Fever
04/01/2010US20100080792 Method for Identifying a MHC Class II-Dependent Tumor-Associated T Helper Cell Antigen
04/01/2010US20100080771 Hepatitis C Virus Inhibitors
04/01/2010US20100080760 Method, device, and system to control pH in pulmonary tissue of a subject
04/01/2010CA2738477A1 Therapeutic regimen comprising peg- interferon, ribavirin and vx-950 for the treatment of hepatitis
04/01/2010CA2738280A1 Peptide compound and method for producing the same
04/01/2010CA2738252A1 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
04/01/2010CA2738147A1 Solid pharmaceutical composition
04/01/2010CA2738128A1 Herbal composition and method for the treatment of viral infection
04/01/2010CA2738027A1 Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis c virus infection
04/01/2010CA2737958A1 Hepatitis c inhibitor compounds
04/01/2010CA2737948A1 Host cell kinases as targets for antiviral therapies against hcv infection
04/01/2010CA2736880A1 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors
04/01/2010CA2736472A1 Pyrine or pyrazine derivatives for treating hcv
04/01/2010CA2723086A1 Antiviral drugs for treatment of arenavirus infection
03/2010
03/31/2010EP2169073A1 Vector for the preparation of immunotherapeutical compositions
03/31/2010EP2169072A1 Multiple RNA polymerase III promoter expression constructs
03/31/2010EP2169054A1 Vaccine for swine edema disease
03/31/2010EP2168987A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain
03/31/2010EP2168984A1 Human antibodies that bind human IL-12 and methods for producing
03/31/2010EP2168972A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity
03/31/2010EP2168951A1 Azolylmethylenehydrazine derivative and use thereof
03/31/2010EP2168598A1 Method of Treatment Using Ligand-Immunogen Conjugates
03/31/2010EP2168597A1 Vaccines comprising aluminium adjuvants and histidine
03/31/2010EP2168596A2 Immunisation against chlamydia trachomatis
03/31/2010EP2168595A1 Pharmaceutical compositions containing the protein nmb1796
03/31/2010EP2168593A1 Oral vaccine compositions
03/31/2010EP2167662A2 Pharmaceutical compounds comprising abasic oligonucleotides
03/31/2010EP2167537A2 Compiled methods for analysing and sorting samples
03/31/2010EP2167536A1 Mhc multimers, methods for their generation, labeling and use
03/31/2010EP2167527A2 Lantibiotic-based compounds having antimicrobial activity
03/31/2010EP2167522A2 Triazole-based aminoglycoside-peptide conjugates and methods of use
03/31/2010EP2167494A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
03/31/2010EP2167490A1 Triazole derivatives having antifungal activity, method for the preparation thereof, and pharmaceutical composition comprising the same
03/31/2010EP2167480A2 Cationic lipids compositions and methods for enhancing immune responses to vaccines
03/31/2010EP2167476A2 Novel hiv reverse transcriptase inhibitors
03/31/2010EP2167196A1 Heterocyclic compounds for the treatment of tuberculosis
03/31/2010EP2167121A1 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
03/31/2010EP2167120A2 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
03/31/2010EP2167097A2 Metal complexes incorporated within biodegradable nanoparticles and their use
03/31/2010EP2167089A1 Therapeutic compositions and the use thereof
03/31/2010EP2167088A1 Therapeutic compositions and the use thereof
03/31/2010EP2167074A2 Antibiotic compounds
03/31/2010EP2167073A1 Terpenes with antifungal activity against malassezia yeasts
03/31/2010EP2167027A1 The use of oestrogen applied to the penis to reduce hiv infection
03/31/2010EP1301194B1 Essential oil combination and therapeutic uses thereof
03/31/2010EP1251869B1 Immunogenic live rotavirus compositions with reduced risk of side effects
03/31/2010EP1194168B1 Methods and products for manipulating uncoupling protein expression
03/31/2010CN101687909A Composition for preventing or treating lung disease
03/31/2010CN101687900A Double-stranded locked nucleic acid compositions
03/31/2010CN101687887A Tricyclic nitrogen containing compounds as antibacterial agents
03/31/2010CN101687884A macrolactone derivatives
03/31/2010CN101687871A Spiro condensed barbituric acid derivatives for use as antibacterial
03/31/2010CN101687870A Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
03/31/2010CN101687808A indazolamide derivatives
03/31/2010CN101687047A Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
03/31/2010CN101687044A Formulations for the oral administration of therapeutic agents and related methods
03/31/2010CN101687028A 疫苗 Vaccine
03/31/2010CN101687027A immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
03/31/2010CN101686995A Modulation of intestinal flora of HIV patients
03/31/2010CN101686990A Antiviral agent
03/31/2010CN101686985A Cytotoxic t cell activator comprising ep4 agonist
03/31/2010CN101686972A Therapeutic compositions and the use thereof
03/31/2010CN101686958A Topical fungicidal agents for treating nail disorders
03/31/2010CN101684162A Preparation method of subprostrata sophora polysaccharide sulfate and subprostrata sophora polysaccharide sulfate prepared by using the method
03/31/2010CN101684148A Novel surface protein of neisseria meningitidis
03/31/2010CN101684147A moraxella catarrhalis proteins
03/31/2010CN101684146A Novel hcv non-structural polypeptide
03/31/2010CN101684116A Isoniazid lipid derivate and compositions thereof
03/31/2010CN101684101A Piperazinone substituted tetracycline derivatives
03/31/2010CN101684084A Tetracycline compounds containing carbamido
03/31/2010CN101683525A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
03/31/2010CN101683524A Method for preparing bacterial ghost by combination of antibacterial peptide and ultrahigh pressure and application thereof
03/31/2010CN101683519A Composition of thymic peptide alpha 1 and thymopeptide-5 and preparation method thereof
03/31/2010CN101683510A Chinese medicine patch for treating cold and pain and method for producing the same
03/31/2010CN101683490A Chinese medicinal granule preparation for preventing and treating influenza A(H1N1) virus occurring in humans and pigs
03/31/2010CN101683469A Traditional Chinese medicine formula for treating dysentery
03/31/2010CN101683452A Animal Chinese medicine oral liquid for preventing and treating infectious bursal disease of fowl and preparation method thereof
03/31/2010CN101683437A Traditional Chinese medicine composition for soothing liver and strengthening spleen and nourishing qi and promoting blood circulation and preparation method thereof
03/31/2010CN101683429A Animal Chinese medicine granular formulation for preventing and treating infectious bursal disease of fowl and preparation method thereof
03/31/2010CN101683423A Application of Chinese medicine composition in preparation of medicament for treating chicken pox
03/31/2010CN101683411A Application of crab apple extract in preparing hepatic or health-care food
03/31/2010CN101683404A Traditional Chinese medicine composition for treating dampness and heat in liver and gallbladder and preparation method thereof
03/31/2010CN101683403A Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof
03/31/2010CN101683396A Extraction method of tropaeolum total lavonoids
03/31/2010CN101683395A Preparation method of anti-avian influenza virus, newcastle disease virus, chicken bursa virus specific transfer and antimicrobial peptide
03/31/2010CN101683389A Injection for treating postpartum comprehensive disease of cattle and preparation method thereof
03/31/2010CN101683369A Medicament for treating skin tinea disease
03/31/2010CN101683366A Pharmaceutical composition for treating colibacillosis of fowl and preparation method thereof
03/31/2010CN101683360A Extraction and purifying technology of propolis flavones and anticancer mechanism thereof
03/31/2010CN101683357A Astragalus polyose solution for aquatic animals and preparation method thereof
03/31/2010CN101683352A Helminthic for aquaculture of aquatic animal and preparation method thereof
03/31/2010CN101683351A Application of phlorizin in preparing hepatic or health-care food
03/31/2010CN101683349A Compound florfenicol powder for treating mycoplasma of pigeon and preparation method thereof
03/31/2010CN101683334A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
03/31/2010CN101683328A Sterilizing agent for aquaculture